PGNY: Multiplikator rega marang pendapatan Progyny Corp

Tandha merek Progyny Corp (PGNY)

Progyny, Inc. (PGNY) maintains resilience against trade conflicts due to its focus on the US domestic market, as confirmed by the current price-to-sales ratio, which has settled at 2.00. This stability is bolstered by B2B contracts for employee reproductive health support, as well as a scalable cloud IT infrastructure that guarantees uninterrupted access to digital healthcare services for all clients.

PGNY Rasio rega marang pendapatan Progyny Inc (04.07.2022 - 16.11.2026)

Progyny, Inc. (PGNY) - rincian metrik lan laporan keuangan

- kuotasi saiki lan rata-rata prakiraan nilai:
Analisis umum perusahaan:PGNY, Progyny Inc
Produk seri Progyny Corp

The P/S ratio reflects the market value of a single unit of revenue, allowing for an assessment of business overvaluation by comparing market capitalization with sales volume. By analyzing the P/S ratio chart, an investor can determine the monetization efficiency of Progyny, Inc. (PGNY) corporate subscriptions for reproductive health services and identify the risk of stock overvaluation should the growth rate of the client base slow down.

Pesaing Progyny, Inc.

HCA (HCA Healthcare) - Rasio kapitalisasi pasar marang pendapatan|Tenet Healthcare Corporation - Kapitalisasi marang pendapatan|Fresenius Medical (FMS) - Rega marang dodolan|Solventum Corp - Multiplikator P/S|Rasio rega marang dodolan EHC|Universal Health Services (UHS) - Rasio rega marang pendapatan|DaVita - Rasio kapitalisasi pasar marang pendapatan|Kapitalisasi marang pendapatan RDNT|OPCH: Rasio kapitalisasi pasar marang pendapatan|Kapitalisasi marang pendapatan SGRY (Surgery Partners, Inc.)|PINC (Premier, Inc.) - Rasio kapitalisasi pasar marang pendapatan|National Vision - Kapitalisasi marang pendapatan|Ardent Health Partners (ARDT) - Rega marang dodolan|Select Medical Inc. - Multiplikator P/S|Rega marang dodolan Apollo Medical Holdings|MD: Multiplikator P/S|Kapitalisasi marang pendapatan US Physical Therapy|Kapitalisasi marang pendapatan PNTG|Organogenesis Holdings Inc. (ORGO) - Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan NUTX (Nutex Health Corp)|AUNA (Auna Health) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan sbc-holdings.com SBC|evolus.com - Rasio rega marang pendapatan|Community Health Systems, Inc. - Multiplikator P/S|SKIN: Rasio rega marang pendapatan|MDWD: Multiplikator P/S|BTMD: Kapitalisasi marang volume dodolan|Kapitalisasi marang pendapatan JYNT|Rega marang dodolan DocGo Inc. DCGO|PIII (P3 Health Partners, Inc.) - Koefisien rega marang pendapatan|GANX (Gain Therapeutics) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S EUDA (EUDA Health Holdings)|BMGL (Basel Medical Group Limited) - Rasio rega marang dodolan|CLGN - Rasio rega marang pendapatan|Rega marang dodolan cuprina.com.sg|CCM: Multiplikator P/S|AMS: Kapitalisasi marang volume dodolan|MRM (MEDIROM Corp) - Multiplikator P/S|ALBT: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S DHAI|Longevity Health Holdings - Rasio kapitalisasi marang pendapatan|Rasio rega marang pendapatan NewGenIvf Group Ltd NIVF|ATIP (atipt.com) - Rasio rega marang dodolan|CMAX: Kapitalisasi marang pendapatan|Rega marang dodolan Kindly Health|ModivCare (MODV) - Rasio rega marang pendapatan|NVOS (novointegrated.com) - Rasio rega marang pendapatan|SSY (SunLink Health Systems Inc.) - Multiplikator P/S|BACK (IMAC Holdings Inc) - Kapitalisasi marang volume dodolan